Clinical trial
Feasibility of Resisted Expiratory Muscle Training for Females Assigned at Birth With Stress Urinary Incontinence: a Pilot Study
NCT07905586 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility of Resisted Expiratory Muscle Training for Females Assigned at Birth With Stress Urinary Incontinence: a Pilot Study
- Lead sponsor
- Thomas Jefferson University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 1, 2027
- Completion date
- June 30, 2028
- Enrollment
- 24 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
stress urinary incontinence
Arms
As registered; 2 arms.
-
Pelvic floor muscle training
Pelvic floor muscle training (PFMT): Participants will be instructed in a home exercise program of PFMT at 5 sets of 5 submaximal repetitions daily. Through the 6 intervention sessions, exercise repetitions will increase to up to 100 per day in gravity dependent positions.
-
Pelvic floor muscle training + expiratory training
Expiratory Muscle Strength Training (EMST): Participants will use a calibrated expiratory resistance device at 50% of MEP, 5 sets of 5 breaths daily.
PFMT: Participants will be instructed in a home exercise program of PFMT at 5 sets of 5 submaximal repetitions daily. Through the 6 intervention sessions, exercise repetitions will increase to up to 100 per day in gravity dependent positions.
Primary endpoints
Registered primary outcome measures; 2 primary.
-
Attrition
Attrition will be assessed as a feasibility outcome to evaluate participant retention throughout the study. Attrition will be defined as the proportion of enrolled participants who discontinue study participation before completing the final study visit (Visit 7). The attrition rate will be calculated by dividing the number of participants who withdraw or discontinue participation before study completion by the total number of participants enrolled, multiplied by 100. The number and percentage of participants who complete the study will also be reported. Reasons for withdrawal or discontinuation will be documented when available. Attrition and retention rates will be summarized descriptively using counts, percentages, and 95% confidence intervals to evaluate the feasibility of participant retention in the study.
-
Eligibility rates
Eligibility rate will be assessed as a feasibility outcome to evaluate the proportion of individuals screened who meet the study's eligibility criteria. The eligibility rate will be calculated by dividing the number of individuals determined to be eligible by the total number of individuals screened and multiplying by 100. Eligibility will be determined based on the study's prespecified inclusion and exclusion criteria, including an ICIQ-UI SF score of at least 6. The number and percentage of individuals who are eligible and ineligible will be summarized descriptively. Reasons for ineligibility will be documented when available. The eligibility rate will be reported as a percentage with a 95% confidence interval to evaluate the feasibility of identifying an appropriate study population.
Lead sponsor's other trials
Thomas Jefferson University, most recent start first.
+387 more trials See the organization page
Similar trials
Same condition (Urinary Incontinence, Stress) and phase, most recent start first.
+384 more trials See the condition page